CD155/SRC complex promotes hepatocellular carcinoma progression via inhibiting the p38 MAPK signalling pathway and correlates with poor prognosis.

An-Li JinChun-Yan ZhangWen-Jing ZhengJing-Rong XianWen-Jing YangTe LiuWei ChenTong LiBei-Li WangBai-Shen PanQian LiJian-Wen ChengPeng-Xiang WangBo HuJian ZhouJia FanXin-Rong Yang Wei Guo

Published in: Clinical and translational medicine (2022)

CD155 promotes HCC progression via the SRC/p38 MAPK signalling pathway. CD155 may represent a predictor for poor postsurgery prognosis in HCC patients.

Keyphrases

poor prognosis
long non coding rna
end stage renal disease
tyrosine kinase
ejection fraction
newly diagnosed
nk cells
signaling pathway
prognostic factors
peritoneal dialysis